#United States #New York #Securities Fraud #Rosen Law Firm #Picard Medical

Investors Alert: Class Action Lawsuit for Picard Medical, Inc.

In a significant development for shareholders of Picard Medical, Inc., the Rosen Law Firm has announced a unique opportunity for investors who purchased shares during a specific time frame. If you acquired Picard Medical common stock between September 2, 2025, and October 31, 2025, you may have a chance to take a leading role in an upcoming securities fraud class-action lawsuit.

Background on the Lawsuit

The lawsuit revolves around claims of misleading statements made by Picard Medical about its financial status and growth potential. The defendants allegedly provided investors with overly optimistic projections concerning the company’s anticipated financial targets for 2027 and its capacity to grow its core Branded Checkout segment both domestically and internationally.

According to legal documents, although the company showcased a confident outlook, they were reportedly concealing material adverse facts regarding the performance of their salesforce. It has been claimed that this salesforce was not adequately prepared to achieve the company's projected growth, which led to misinformation being circulated among investors. As a result, when the truth became apparent, many investors suffered significant financial losses.

Important Deadlines

For investors looking to become actively involved, there is a critical deadline to consider. To potentially serve as the lead plaintiff in this class action, you must file your motion by April 13, 2026. This is a pivotal date for those who wish to not only advocate for their interests but also represent fellow shareholders who may have been affected by the purported fraud.

Joining the class action comes at no personal expense to you; fees are typically handled on a contingency basis. This means that legal fees will only be collected if the firm successfully recoups funds for investors, alleviating individual financial burdens.

For those considering this opportunity, you can reach out for more information or to join the suit and direct your inquiries to Phillip Kim, Esq. at the Rosen Law Firm via their toll-free number 866-767-3653, or visit their website at rosenlegal.com.

The Rosen Law Firm's Credentials

The Rosen Law Firm has established a strong reputation for its work on behalf of investors globally, particularly in securities class actions and shareholder derivative litigation. With a successful track record of achieving substantial settlements, the firm is known for aggressively representing its clients’ interests. In 2017, they were recognized for securing the largest ever securities class action settlement against a Chinese company. Being ranked in the top echelons of law firms specializing in securities actions, they have reclaimed millions of dollars for investors, solidifying their status in the legal community.

Additionally, with founding partner Laurence Rosen being honored as a Titan of Plaintiffs' Bar by Law360 in 2020, investors can trust that they are backed by an experienced team that advocates fervently for client rights.

Next Steps for Investors

• - Joining the Class Action: To take part in the class action and establish yourself as a lead plaintiff, visiting the provided links on the law firm's website is essential. Make sure to act swiftly, as the deadline is approaching.
• - Staying Informed: For updates on the lawsuit and other important information related to Picard Medical, follow the Rosen Law Firm on their social media platforms, including LinkedIn, Twitter, and Facebook.

This opportunity serves as a reminder of the importance of investor vigilance and the collective strength found in class action lawsuits. If you believe you have been wronged by misleading corporate actions, taking steps to join such a class can empower you and your fellow investors to seek justice together.

Final Notes

Remember, as of now, no class has been officially certified, and until it is, you are encouraged to choose counsel carefully. You also have the option to remain uninvolved at this time should you prefer. Your eligibility for any potential recovery is not contingent upon taking immediate action. However, participating could lead to recovery for losses suffered due to the alleged deceit by Picard Medical.

In this rapidly changing environment, staying informed and proactive can make all the difference for investors looking to regain their trust and investments in the market.

This is a crucial moment for investors in Picard Medical, and understanding your rights and options could lead to a path for restitution.